Stockreport

Onconova Therapeutics Announces Cooperative Research and Development Agreement for Rigosertib with the National Cancer Institute

Onconova Therapeutics, Inc.  (ONTX) 
Last onconova therapeutics, inc. earnings: 11/12 05:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.onconova.com/investor-overview
PDF Agreement related to study of rigosertib in pediatric RASopathiesClinical trial in pediatric patients to be conducted by the National Cancer InstituteRASopathies are orp [Read more]